These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18813783)

  • 1. Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors.
    Joo KM; Song SY; Park K; Kim MH; Jin J; Kang BG; Jang MJ; Lee GS; Kim MS; Nam DH
    Int J Oncol; 2008 Oct; 33(4):705-12. PubMed ID: 18813783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor.
    Joo KM; Park K; Kong DS; Song SY; Kim MH; Lee GS; Kim MS; Nam DH
    Oncol Rep; 2008 Jan; 19(1):17-23. PubMed ID: 18097571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X; Sui M; Fan W
    Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y; Sadhukha T; Ma L; Panyam J
    J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.
    Gerstner ER; Fine RL
    J Clin Oncol; 2007 Jun; 25(16):2306-12. PubMed ID: 17538177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
    Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease.
    Yang JM; Yang GY; Medina DJ; Vassil AD; Liao J; Hait WN
    Biochem Biophys Res Commun; 1999 Dec; 266(1):167-73. PubMed ID: 10581184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors.
    Fine RL; Chen J; Balmaceda C; Bruce JN; Huang M; Desai M; Sisti MB; McKhann GM; Goodman RR; Bertino JS; Nafziger AN; Fetell MR
    Clin Cancer Res; 2006 Oct; 12(19):5770-6. PubMed ID: 17020983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J; Liu P; Mao H; Wanga A; Zhang X
    Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma.
    Warmann SW; Heitmann H; Teichmann B; Gratz KF; Ruck P; Hunger M; Fuchs J
    Pediatr Hematol Oncol; 2005; 22(5):373-86. PubMed ID: 16020127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel modifies the accumulation of tumor-diagnostic tracers in different ways in P-glycoprotein-positive and negative cancer cells.
    Krasznai ZT; Péli-Szabó J; Németh E; Balkay L; Szabó G; Goda K; Galuska L; Trón L; Major T; Hernádi Z
    Eur J Pharm Sci; 2006 Jun; 28(3):249-56. PubMed ID: 16574387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic drug resistance in brain tumors.
    Phillips PC
    Neurol Clin; 1991 May; 9(2):383-404. PubMed ID: 1682794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice.
    Kemper EM; Cleypool C; Boogerd W; Beijnen JH; van Tellingen O
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):173-8. PubMed ID: 14605863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological stress induces chemoresistance in breast cancer by upregulating mdr1.
    Su F; Ouyang N; Zhu P; Ouyang N; Jia W; Gong C; Ma X; Xu H; Song E
    Biochem Biophys Res Commun; 2005 Apr; 329(3):888-97. PubMed ID: 15752739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel nanoparticles for the potential treatment of brain tumors.
    Koziara JM; Lockman PR; Allen DD; Mumper RJ
    J Control Release; 2004 Sep; 99(2):259-69. PubMed ID: 15380635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport?
    Václavíková R; Boumendjel A; Ehrlichová M; Kovár J; Gut I
    Bioorg Med Chem; 2006 Jul; 14(13):4519-25. PubMed ID: 16516478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.